CN Stock MarketDetailed Quotes

000963 Huadong Medicine

Watchlist
  • 38.98
  • +2.48+6.79%
Market Closed Nov 29 15:00 CST
68.38BMarket Cap21.29P/E (TTM)

Huadong Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
3.56%31.48B
2.84%20.97B
2.93%10.41B
7.71%40.62B
9.10%30.39B
12.02%20.39B
13.23%10.11B
9.12%37.71B
7.45%27.86B
5.93%18.2B
Operating revenue
3.56%31.48B
2.84%20.97B
2.93%10.41B
7.71%40.62B
9.10%30.39B
12.02%20.39B
13.23%10.11B
9.12%37.71B
7.45%27.86B
5.93%18.2B
Other operating revenue
----
4.01%142.98M
----
60.37%362.43M
----
50.97%137.47M
----
55.26%226M
----
93.76%91.06M
Total operating cost
2.72%28.29B
2.35%18.88B
2.42%9.33B
7.27%37.08B
8.33%27.54B
11.67%18.44B
13.49%9.11B
8.96%34.57B
7.17%25.42B
5.61%16.52B
Operating cost
2.51%21.23B
1.38%14.11B
4.21%7.08B
6.93%27.46B
8.97%20.71B
13.67%13.92B
14.81%6.79B
7.20%25.68B
6.66%19.01B
5.64%12.24B
Operating tax surcharges
5.63%163.79M
4.05%111.01M
5.99%56.33M
11.65%232.59M
6.38%155.06M
11.03%106.69M
6.58%53.15M
17.53%208.32M
10.37%145.77M
8.46%96.08M
Operating expense
1.40%4.73B
6.19%3.27B
-4.16%1.57B
4.90%6.65B
3.53%4.66B
1.68%3.08B
14.59%1.64B
16.79%6.33B
8.12%4.5B
1.82%3.03B
Administration expense
6.62%1.18B
-0.95%714.63M
1.54%335.17M
13.73%1.42B
15.33%1.11B
26.12%721.48M
9.08%330.09M
7.01%1.25B
11.50%958.82M
6.99%572.05M
Financial expense
-40.63%38.02M
-58.06%23.42M
-74.08%7.56M
-34.59%51.19M
230.55%64.03M
925.12%55.85M
261.66%29.15M
254.50%78.26M
21.84%19.37M
-44.35%5.45M
-Interest expense (Financial expense)
2.69%86.59M
0.27%55.55M
-33.12%23.05M
-6.38%119.51M
51.30%84.32M
32.55%55.4M
64.47%34.47M
44.10%127.65M
-7.05%55.73M
12.31%41.8M
-Interest Income (Financial expense)
-29.72%-80.01M
-60.93%-53.14M
-95.41%-24.41M
9.00%-94.05M
18.60%-61.68M
33.90%-33.02M
48.30%-12.49M
-28.54%-103.35M
-16.85%-75.78M
-29.93%-49.96M
Research and development
12.83%948.66M
15.17%643.11M
6.08%281.64M
25.08%1.27B
6.68%840.79M
-1.45%558.41M
-16.83%265.49M
3.71%1.02B
8.32%788.16M
29.49%566.6M
Credit Impairment Loss
-37.88%-57.94M
-59.03%-57.94M
----
62.49%-25.76M
41.61%-42.02M
49.38%-36.43M
----
-64.76%-68.69M
-88.08%-71.97M
-88.08%-71.97M
Asset Impairment Loss
----
----
----
-70.60%-6.52M
---3.18M
---3.18M
----
77.40%-3.82M
----
--0
Other net revenue
118.10%26.51M
95.01%-7.15M
85.10%-7.36M
-5.18%-88.94M
-196.03%-146.45M
-306.01%-143.26M
-195.02%-49.37M
-528.20%-84.56M
-179.02%-49.47M
-173.70%-35.28M
Fair value change income
----
----
---25.36K
-148.32%-13.76M
---6.62M
---5.1M
----
--28.47M
----
----
Invest income
48.64%-86.71M
65.05%-47.85M
23.63%-47.16M
-55.21%-219.71M
-70.25%-168.84M
-155.96%-136.89M
-120.85%-61.75M
-46.98%-141.56M
-65.28%-99.17M
1.80%-53.48M
-Including: Investment income associates
62.45%-54.56M
79.03%-25.26M
28.99%-37.5M
-62.94%-188.39M
-79.47%-145.31M
-179.12%-120.43M
-154.37%-52.82M
-116.38%-115.62M
-326.81%-80.97M
-88.80%-43.15M
Asset deal income
-39.32%2.18M
39.99%4.93M
169.15%1.52M
-47.69%4.32M
-35.68%3.59M
-58.62%3.52M
-494.37%-2.2M
26,209.73%8.26M
3,819.50%5.58M
4,566.05%8.51M
Other revenue
139.29%168.98M
169.17%93.71M
162.72%38.31M
85.91%172.49M
-39.17%70.62M
-57.36%34.81M
36.68%14.58M
-46.89%92.78M
-26.51%116.09M
-40.56%81.65M
Operating profit
18.71%3.22B
15.72%2.08B
12.39%1.07B
12.79%3.45B
13.49%2.71B
9.25%1.8B
7.46%953.94M
7.20%3.06B
5.18%2.39B
3.63%1.65B
Add:Non operating Income
110.42%7.44M
75.66%5.22M
-6.74%1.3M
564.38%50.55M
-29.74%3.54M
-31.53%2.97M
67.05%1.39M
183.66%7.61M
-71.13%5.03M
420.03%4.34M
Less:Non operating expense
270.46%88.91M
131.83%37.78M
-13.99%5.2M
-1.18%37.49M
-11.34%24M
88.17%16.3M
12.94%6.05M
22.93%37.94M
36.11%27.07M
41.37%8.66M
Total profit
16.58%3.13B
14.76%2.05B
12.53%1.07B
14.35%3.47B
13.68%2.69B
8.73%1.79B
7.48%949.28M
7.20%3.03B
4.32%2.36B
3.70%1.64B
Less:Income tax cost
15.51%571.28M
4.36%360.34M
9.82%207.94M
24.29%619.59M
38.06%494.56M
19.91%345.28M
11.94%189.35M
1.96%498.5M
10.41%358.22M
19.61%287.94M
Net profit
16.82%2.56B
17.25%1.69B
13.20%860.25M
12.39%2.85B
9.33%2.19B
6.35%1.44B
6.43%759.93M
8.30%2.53B
3.30%2.01B
0.85%1.35B
Net profit from continuing operation
16.82%2.56B
17.25%1.69B
13.20%860.25M
12.39%2.85B
9.33%2.19B
6.35%1.44B
6.43%759.93M
8.30%2.53B
3.30%2.01B
0.85%1.35B
Less:Minority Profit
-93.83%277.57K
-229.42%-7.81M
-146.68%-2.17M
-77.44%7.54M
-81.89%4.5M
-54.77%6.03M
-52.00%4.64M
-9.69%33.41M
-46.88%24.85M
-68.37%13.33M
Net profit of parent company owners
17.05%2.56B
18.29%1.7B
14.18%862.41M
13.59%2.84B
10.48%2.19B
6.96%1.43B
7.23%755.28M
8.58%2.5B
4.54%1.98B
3.09%1.34B
Earning per share
Basic earning per share
17.06%1.4644
18.07%0.9675
14.20%0.4929
13.55%1.6219
10.47%1.251
6.96%0.8194
7.23%0.4316
8.58%1.4283
4.54%1.1324
3.10%0.7661
Diluted earning per share
17.08%1.4639
18.27%0.9686
14.21%0.4928
13.47%1.6207
10.41%1.2503
6.91%0.819
7.20%0.4315
8.58%1.4283
4.54%1.1324
3.10%0.7661
Other composite income
554.51%17.68M
29.29%-6.29M
229.47%40.59M
223.84%50.51M
79.56%-3.89M
90.95%-8.89M
-108.80%-31.35M
-69.40%-40.78M
-116.46%-19.03M
-298.24%-98.25M
Other composite income of parent company owners
554.51%17.68M
29.29%-6.29M
229.47%40.59M
223.84%50.51M
79.56%-3.89M
90.95%-8.89M
-108.80%-31.35M
-69.40%-40.78M
-116.46%-19.03M
-298.24%-98.25M
Total composite income
17.84%2.58B
17.54%1.68B
23.64%900.84M
16.26%2.9B
10.18%2.19B
13.96%1.43B
4.23%728.57M
7.66%2.49B
-3.43%1.99B
-9.80%1.26B
Total composite income of parent company owners
18.07%2.58B
18.58%1.69B
24.74%903M
17.53%2.89B
11.35%2.19B
14.70%1.42B
5.02%723.93M
7.94%2.46B
-2.41%1.96B
-7.97%1.24B
Total composite income of minority owners
-93.83%277.57K
-229.42%-7.81M
-146.68%-2.17M
-77.44%7.54M
-81.89%4.5M
-54.77%6.03M
-52.00%4.64M
-9.69%33.41M
-46.88%24.85M
-68.37%13.33M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 3.56%31.48B2.84%20.97B2.93%10.41B7.71%40.62B9.10%30.39B12.02%20.39B13.23%10.11B9.12%37.71B7.45%27.86B5.93%18.2B
Operating revenue 3.56%31.48B2.84%20.97B2.93%10.41B7.71%40.62B9.10%30.39B12.02%20.39B13.23%10.11B9.12%37.71B7.45%27.86B5.93%18.2B
Other operating revenue ----4.01%142.98M----60.37%362.43M----50.97%137.47M----55.26%226M----93.76%91.06M
Total operating cost 2.72%28.29B2.35%18.88B2.42%9.33B7.27%37.08B8.33%27.54B11.67%18.44B13.49%9.11B8.96%34.57B7.17%25.42B5.61%16.52B
Operating cost 2.51%21.23B1.38%14.11B4.21%7.08B6.93%27.46B8.97%20.71B13.67%13.92B14.81%6.79B7.20%25.68B6.66%19.01B5.64%12.24B
Operating tax surcharges 5.63%163.79M4.05%111.01M5.99%56.33M11.65%232.59M6.38%155.06M11.03%106.69M6.58%53.15M17.53%208.32M10.37%145.77M8.46%96.08M
Operating expense 1.40%4.73B6.19%3.27B-4.16%1.57B4.90%6.65B3.53%4.66B1.68%3.08B14.59%1.64B16.79%6.33B8.12%4.5B1.82%3.03B
Administration expense 6.62%1.18B-0.95%714.63M1.54%335.17M13.73%1.42B15.33%1.11B26.12%721.48M9.08%330.09M7.01%1.25B11.50%958.82M6.99%572.05M
Financial expense -40.63%38.02M-58.06%23.42M-74.08%7.56M-34.59%51.19M230.55%64.03M925.12%55.85M261.66%29.15M254.50%78.26M21.84%19.37M-44.35%5.45M
-Interest expense (Financial expense) 2.69%86.59M0.27%55.55M-33.12%23.05M-6.38%119.51M51.30%84.32M32.55%55.4M64.47%34.47M44.10%127.65M-7.05%55.73M12.31%41.8M
-Interest Income (Financial expense) -29.72%-80.01M-60.93%-53.14M-95.41%-24.41M9.00%-94.05M18.60%-61.68M33.90%-33.02M48.30%-12.49M-28.54%-103.35M-16.85%-75.78M-29.93%-49.96M
Research and development 12.83%948.66M15.17%643.11M6.08%281.64M25.08%1.27B6.68%840.79M-1.45%558.41M-16.83%265.49M3.71%1.02B8.32%788.16M29.49%566.6M
Credit Impairment Loss -37.88%-57.94M-59.03%-57.94M----62.49%-25.76M41.61%-42.02M49.38%-36.43M-----64.76%-68.69M-88.08%-71.97M-88.08%-71.97M
Asset Impairment Loss -------------70.60%-6.52M---3.18M---3.18M----77.40%-3.82M------0
Other net revenue 118.10%26.51M95.01%-7.15M85.10%-7.36M-5.18%-88.94M-196.03%-146.45M-306.01%-143.26M-195.02%-49.37M-528.20%-84.56M-179.02%-49.47M-173.70%-35.28M
Fair value change income -----------25.36K-148.32%-13.76M---6.62M---5.1M------28.47M--------
Invest income 48.64%-86.71M65.05%-47.85M23.63%-47.16M-55.21%-219.71M-70.25%-168.84M-155.96%-136.89M-120.85%-61.75M-46.98%-141.56M-65.28%-99.17M1.80%-53.48M
-Including: Investment income associates 62.45%-54.56M79.03%-25.26M28.99%-37.5M-62.94%-188.39M-79.47%-145.31M-179.12%-120.43M-154.37%-52.82M-116.38%-115.62M-326.81%-80.97M-88.80%-43.15M
Asset deal income -39.32%2.18M39.99%4.93M169.15%1.52M-47.69%4.32M-35.68%3.59M-58.62%3.52M-494.37%-2.2M26,209.73%8.26M3,819.50%5.58M4,566.05%8.51M
Other revenue 139.29%168.98M169.17%93.71M162.72%38.31M85.91%172.49M-39.17%70.62M-57.36%34.81M36.68%14.58M-46.89%92.78M-26.51%116.09M-40.56%81.65M
Operating profit 18.71%3.22B15.72%2.08B12.39%1.07B12.79%3.45B13.49%2.71B9.25%1.8B7.46%953.94M7.20%3.06B5.18%2.39B3.63%1.65B
Add:Non operating Income 110.42%7.44M75.66%5.22M-6.74%1.3M564.38%50.55M-29.74%3.54M-31.53%2.97M67.05%1.39M183.66%7.61M-71.13%5.03M420.03%4.34M
Less:Non operating expense 270.46%88.91M131.83%37.78M-13.99%5.2M-1.18%37.49M-11.34%24M88.17%16.3M12.94%6.05M22.93%37.94M36.11%27.07M41.37%8.66M
Total profit 16.58%3.13B14.76%2.05B12.53%1.07B14.35%3.47B13.68%2.69B8.73%1.79B7.48%949.28M7.20%3.03B4.32%2.36B3.70%1.64B
Less:Income tax cost 15.51%571.28M4.36%360.34M9.82%207.94M24.29%619.59M38.06%494.56M19.91%345.28M11.94%189.35M1.96%498.5M10.41%358.22M19.61%287.94M
Net profit 16.82%2.56B17.25%1.69B13.20%860.25M12.39%2.85B9.33%2.19B6.35%1.44B6.43%759.93M8.30%2.53B3.30%2.01B0.85%1.35B
Net profit from continuing operation 16.82%2.56B17.25%1.69B13.20%860.25M12.39%2.85B9.33%2.19B6.35%1.44B6.43%759.93M8.30%2.53B3.30%2.01B0.85%1.35B
Less:Minority Profit -93.83%277.57K-229.42%-7.81M-146.68%-2.17M-77.44%7.54M-81.89%4.5M-54.77%6.03M-52.00%4.64M-9.69%33.41M-46.88%24.85M-68.37%13.33M
Net profit of parent company owners 17.05%2.56B18.29%1.7B14.18%862.41M13.59%2.84B10.48%2.19B6.96%1.43B7.23%755.28M8.58%2.5B4.54%1.98B3.09%1.34B
Earning per share
Basic earning per share 17.06%1.464418.07%0.967514.20%0.492913.55%1.621910.47%1.2516.96%0.81947.23%0.43168.58%1.42834.54%1.13243.10%0.7661
Diluted earning per share 17.08%1.463918.27%0.968614.21%0.492813.47%1.620710.41%1.25036.91%0.8197.20%0.43158.58%1.42834.54%1.13243.10%0.7661
Other composite income 554.51%17.68M29.29%-6.29M229.47%40.59M223.84%50.51M79.56%-3.89M90.95%-8.89M-108.80%-31.35M-69.40%-40.78M-116.46%-19.03M-298.24%-98.25M
Other composite income of parent company owners 554.51%17.68M29.29%-6.29M229.47%40.59M223.84%50.51M79.56%-3.89M90.95%-8.89M-108.80%-31.35M-69.40%-40.78M-116.46%-19.03M-298.24%-98.25M
Total composite income 17.84%2.58B17.54%1.68B23.64%900.84M16.26%2.9B10.18%2.19B13.96%1.43B4.23%728.57M7.66%2.49B-3.43%1.99B-9.80%1.26B
Total composite income of parent company owners 18.07%2.58B18.58%1.69B24.74%903M17.53%2.89B11.35%2.19B14.70%1.42B5.02%723.93M7.94%2.46B-2.41%1.96B-7.97%1.24B
Total composite income of minority owners -93.83%277.57K-229.42%-7.81M-146.68%-2.17M-77.44%7.54M-81.89%4.5M-54.77%6.03M-52.00%4.64M-9.69%33.41M-46.88%24.85M-68.37%13.33M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data